Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
announced the presentation of clinical and preclinical data in oral
presentation and discussion sessions at the 12 th
International Mesothelioma Interest Group (iMig) Conference being held
October 22-24, 2014, at the Cape Town International Conference Centre in
Cape Town, South Africa.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.